✦ LIBER ✦

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

✍ Scribed by Tanja D. de Gruijl; Alfons J. M. van den Eertwegh; Herbert M. Pinedo; Rik J. Scheper

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 311 KB
Volume: 57
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-008-0536-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dendritic/tumor fusion cell-based vaccin

Dendritic/tumor fusion cell-based vaccination against cancer

✍ Shigeo Koido; Eiichi Hara; Sadamu Homma; Kiyotaka Fujise; Jianlin Gong; Hisao Ta 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 103 KB

Dendritic cells derived from metastatic

Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell–autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions

✍ Andreia R. Neves; Luis Felipe C. Ensina; Luciene B. Anselmo; Katia R. M. Leite; 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 271 KB

Antigen-specific cancer immunotherapy us

Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine

✍ Edwin Y. Chang; Chien-Hung Chen; Hongxiu Ji; Tian-Li Wang; Kenneth Hung; Bruce P 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 147 KB 👁 1 views

Granulocyte-macrophage colony-stimulating factor (GM-CSF)-transduced autologous tumor cell-based vaccines are currently one of the major forms of cancer vaccines. However, the preparation of GM-CSF-transduced autologous tumor vaccines is time-consuming and technically challenging. In addition, the h

Cell-based vaccines for renal cell carci

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

✍ Bernhard Frankenberger; Sybille Regn; Christiane Geiger; Elfriede Noessner; Chri 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 357 KB

Tumor endothelial marker 8 expression le

Tumor endothelial marker 8 expression levels in dendritic cell-based cancer vaccines are related to clinical outcome

✍ Franco Maria Venanzi; Massimiliano Petrini; Laura Fiammenghi; Elisabetta Bolli; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 444 KB

Serological response of melanoma patient

Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

✍ Philip O. Livingston; Anthony P. Albino; Tae June C. Chung; Francisco X. Real; A 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB